CURANEX PHARMACEUTICALS INC (CURX) Stock Overview
USA - NASDAQ:CURX - Common Stock
CURX Key Statistics, Chart & Performance
The current stock price of CURX is 0.77 USD.
CURX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 44.53 | 680.63B | ||
| JNJ | JOHNSON & JOHNSON | 17.68 | 425.81B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 14.38 | 251.12B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.85 | 237.26B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.48 | 226.86B | ||
| MRK | MERCK & CO. INC. | 10.14 | 195.04B | ||
| PFE | PFIZER INC | 7.01 | 135.11B | ||
| SNY | SANOFI-ADR | 10.13 | 110.17B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.45 | 88.41B | ||
| GSK | GSK PLC-SPON ADR | 8.76 | 79.58B | ||
| ZTS | ZOETIS INC | 22.51 | 62.04B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 50.76 | 46.49B |
Related stock screener links
About CURX
Company Profile
Curanex Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Jericho, New York. The company went IPO on 2025-08-26. Curanex Pharmaceuticals Inc is a developmental stage pharmaceutical company. The firm is engaged in discovering, developing, and commercializing botanical drugs to treat patients suffering from inflammatory diseases and to develop therapies that offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections. Its lead candidate, Phyto-N, is a botanical extract from a single plant with anti-inflammatory properties that act via multiple targets and mechanisms. Its drug development pipelines encompass six various therapeutic areas: ulcerative colitis, atopic dermatitis, COVID-19, diabetes, NAFLD, and gout. Phyto-N is being developed as an orally administered alternative for patients with moderate to severe ulcerative colitis, aiming to address limitations of current treatments. The firm's two botanical drugs include Veregen (sinecatechins) and Fulyzaq/Mytesi (crofelemer).
Company Info
CURANEX PHARMACEUTICALS INC
2 Jericho Plaza, Suite101B
Jericho NEW YORK US
Employees: 0
Phone: 17186736078
CURANEX PHARMACEUTICALS INC / CURX FAQ
What is the stock price of CURANEX PHARMACEUTICALS INC today?
The current stock price of CURX is 0.77 USD. The price decreased by -11.49% in the last trading session.
What is the ticker symbol for CURANEX PHARMACEUTICALS INC stock?
The exchange symbol of CURANEX PHARMACEUTICALS INC is CURX and it is listed on the Nasdaq exchange.
On which exchange is CURX stock listed?
CURX stock is listed on the Nasdaq exchange.
What is CURANEX PHARMACEUTICALS INC worth?
CURANEX PHARMACEUTICALS INC (CURX) has a market capitalization of 21.37M USD. This makes CURX a Nano Cap stock.
How many employees does CURANEX PHARMACEUTICALS INC have?
CURANEX PHARMACEUTICALS INC (CURX) currently has 0 employees.
Should I buy CURANEX PHARMACEUTICALS INC (CURX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CURX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CURX, evaluating the profitability, health, valuation and growth aspects
- CURANEX PHARMACEUTICALS INC (CURX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CURANEX PHARMACEUTICALS INC (CURX) Sales and EPS estimates to see what analysts future expectations are.
- CURANEX PHARMACEUTICALS INC (CURX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CURANEX PHARMACEUTICALS INC (CURX) Insider and Institutional Ownership to learn about the owners and their transactions.
- CURANEX PHARMACEUTICALS INC (CURX) Stock Chart to make your own analysis
- CURANEX PHARMACEUTICALS INC (CURX) Latest news and press-releases to stay up to date.
Does CURANEX PHARMACEUTICALS INC (CURX) stock pay dividends?
CURX does not pay a dividend.
What is the Short Interest ratio of CURANEX PHARMACEUTICALS INC (CURX) stock?
The outstanding short interest for CURANEX PHARMACEUTICALS INC (CURX) is 3.15% of its float. Check the ownership tab for more information on the CURX short interest.
CURX Technical Analysis
CURX Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |